This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks.com highlights: Apache, PTC, NeoGenomics, Titan International and AMC Entertainment Holdings
by Zacks Equity Research
Zacks.com highlights: Apache, PTC, NeoGenomics, Titan International and AMC Entertainment Holdings
Abandon These 5 Toxic Stocks or Sell Short for Profit
by Zacks Equity Research
Pricey toxic stocks are susceptible to external shocks and are loaded with huge debt.
PTC Inc. (PTC) in Focus: Stock Moves 7.6% Higher
by Zacks Equity Research
PTC Inc. (PTC) was a big mover last session, as the company saw its shares nearly 8% on the day amid huge volumes.
5 Toxic Stocks to Abandon or Sell Short for Gains
by Zacks Equity Research
Toxic stocks are susceptible to external shocks and are loaded with high amounts of debts. Also, the price of toxic stocks is irrationally high.
Zacks.com featured highlights: PTC, Apache, Incyte, Titan International and Carbonite
by Zacks Equity Research
Zacks.com featured highlights: PTC, Apache, Incyte, Titan International and Carbonite
5 Toxic Stocks to Discard or Sell Short for Profit
by Zacks Equity Research
Toxic stocks are exposed to outside shocks and are burdened with high levels of debts. Also, the price of toxic stocks is artificially inflated.
5 Toxic Stocks to Abandon or Sell Short for Profit
by Zacks Equity Research
Toxic stocks are susceptible to external shocks and are burdened with high levels of debt. Also, the price of toxic stocks is irrationally inflated.
Zacks.com featured highlights: PTC, Continental Resources, Apache, Titan International and First Majestic Silver
by Zacks Equity Research
Zacks.com featured highlights: PTC, Continental Resources, Apache, Titan International and First Majestic Silver
5 Toxic Stocks to Cast Aside or Sell Short for Profit
by Zacks Equity Research
Toxic stocks are vulnerable to external shocks and are loaded with high levels of debt. Also, the price of toxic stocks is unreasonably high.
Zacks.com featured highlights: PTC, Continental Resources Halcon Resources, Apache and Zillow Group
by Zacks Equity Research
Zacks.com featured highlights: PTC, Continental Resources Halcon Resources, Apache and Zillow Group
5 Toxic Stocks to Avoid or Sell Short for Profit
by Zacks Equity Research
The inflated price of the toxic stocks can be ascribed to either an irrational exuberance associated with them or some serious fundamental lacunae in the stock.
3D Systems to Power Printers with PTC's ThingWorx Platform
by Zacks Equity Research
3D Systems Corporation (DDD) recently announced that it has chosen computer software and services provider, PTC Inc.'s (PTC) ThingWorx Platform, to enable its 3D printers to perform intelligent monitoring, remote service and maintenance.
Zacks.com featured highlights: Covanta Holding, PTC, Etsy, Vertex Pharmaceuticals and Live Nation Entertainment
by Zacks Equity Research
Zacks.com featured highlights: Covanta Holding, PTC, Etsy, Vertex Pharmaceuticals and Live Nation Entertainment
5 Toxic Stocks to Steer Clear Of or Play Short Right Now
by Zacks Equity Research
High price of the toxic stocks can be ascribed to an irrational exuberance associated with them or some serious fundamental lacunae. Presence of such stocks in your portfolio may result loss of wealth.
Zacks.com featured highlights: Covanta Holding, PTC, Etsy, KCG Holdings and Incyte
by Zacks Equity Research
Zacks.com featured highlights: Covanta Holding, PTC, Etsy, KCG Holdings and Incyte
5 Toxic Stocks to Dispose of or Play Short for Profit
by Zacks Equity Research
Just like picking stocks with growth potential, pinpointing toxic stocks and discarding them at the right time is the key to shield your portfolio from big losses or make profits by short selling them.
Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
5 Toxic Stocks to Shun or Play Short Right Now
by Zacks Equity Research
Just like picking up stocks with strong growth potential, pinpointing toxic stocks and abandoning them at the right time is the key to protect your portfolio from big losses or make profits by short selling them.
Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals
5 Toxic Stocks to Get Rid Of or Play Short to Make Gains
by Zacks Equity Research
Exaggerated price of toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental lacuna.
Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals
5 Toxic Stocks to Dump or Play Short to Make Gains
by Zacks Equity Research
Unreasonably high price of toxic stocks is only short-lived as the intrinsic value of these stocks is lower than the current bloated price.